Similar articles

• Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis--authors' response.

  Koh WJ, Shim TS. Koh WJ, et al. J Antimicrob Chemother. 2009 Nov;64(5):1119-20. doi: 10.1093/jac/dkp344. Epub 2009 Sep 10. J Antimicrob Chemother. 2009. PMID: 19744986 No abstract available.
• Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.

  Sotgiu G, Lange C, Richardson MD, Matteelli A, Centis R, Eker B, Guenther G, Spanevello A, Migliori GB; TBNET. Sotgiu G, et al. J Antimicrob Chemother. 2009 Oct;64(4):879-83; author reply 883-4. doi: 10.1093/jac/dkp265. Epub 2009 Aug 3. J Antimicrob Chemother. 2009. PMID: 19651787 No abstract available.
• Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.

  Koh WJ, Kwon OJ, Gwak H, Chung JW, Cho SN, Kim WS, Shim TS. Koh WJ, et al. J Antimicrob Chemother. 2009 Aug;64(2):388-91. doi: 10.1093/jac/dkp171. Epub 2009 May 25. J Antimicrob Chemother. 2009. PMID: 19468028
• [The analysis of clinical data about the treatment of linezolid against tuberculosis].

  Nie WJ, Chu NH. Nie WJ, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2013 Aug;36(8):601-3. Zhonghua Jie He He Hu Xi Za Zhi. 2013. PMID: 24252739 Review. Chinese. No abstract available.
• Linezolid for the treatment of drug-resistant tuberculosis in children: a review and recommendations.

  Garcia-Prats AJ, Rose PC, Hesseling AC, Schaaf HS. Garcia-Prats AJ, et al. Tuberculosis (Edinb). 2014 Mar;94(2):93-104. doi: 10.1016/j.tube.2013.10.003. Epub 2013 Oct 27. Tuberculosis (Edinb). 2014. PMID: 24388605 Review.